SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX-Reaffirm Outperform Recommendation-Gruntal Research
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PAUL ROBERT ST. ONGE who wrote (16)12/18/1996 1:55:00 PM
From: James Silverman   of 23
 
Thanks Paul,
I saw the news. Big positive. The bigger story will be if a similar pattern follows with Cardizem CD and HMR. Should they drop the suit, ADRX is a "screaming" buy at $14.

Looks good, the story is getting better.

Do you have a contact at ADRX? I have some ideas to pass along re: adrx should you have someone you can forward them to.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News